146 related articles for article (PubMed ID: 3508718)
21. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma.
Fukumoto S; Matsumoto T; Ikeda K; Yamashita T; Watanabe T; Yamaguchi K; Kiyokawa T; Takatsuki K; Shibuya N; Ogata E
Arch Intern Med; 1988 Apr; 148(4):921-5. PubMed ID: 2895617
[TBL] [Abstract][Full Text] [Related]
23. [How to deal with those low parathyroid hormone values in dialysis patients?].
Jean G; Lafage-Proust MH; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
Nephrol Ther; 2012 Nov; 8(6):462-7. PubMed ID: 22627198
[TBL] [Abstract][Full Text] [Related]
24. Treatment of malignancy-associated hypercalcemia with YM175, a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patients.
Fukumoto S; Matsumoto T; Takebe K; Onaya T; Eto S; Nawata H; Ogata E
J Clin Endocrinol Metab; 1994 Jul; 79(1):165-70. PubMed ID: 8027221
[TBL] [Abstract][Full Text] [Related]
25. Validation of a locally derived serum calcium adjustment equation: relationship with total 25(OH) vitamin D and PTH levels.
Scargill JJ; Guy JM
J Clin Pathol; 2017 Jan; 70(1):69-74. PubMed ID: 27325797
[TBL] [Abstract][Full Text] [Related]
26. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Br J Cancer; 1994 Jul; 70(1):169-72. PubMed ID: 8018531
[TBL] [Abstract][Full Text] [Related]
27. Phosphate depletion in the rat: effect of bisphosphonates and the calcemic response to PTH.
Jara A; Lee E; Stauber D; Moatamed F; Felsenfeld AJ; Kleeman CR
Kidney Int; 1999 Apr; 55(4):1434-43. PubMed ID: 10201008
[TBL] [Abstract][Full Text] [Related]
28. Gestational hypercalcemia: Prevalence and biochemical profile.
Schoenmakers I; Piec I; Baban S; Bärebring L; Green D; Washbourne CJ; Tang JCY; Fraser WD; Augustin H
J Steroid Biochem Mol Biol; 2020 May; 199():105611. PubMed ID: 32007562
[TBL] [Abstract][Full Text] [Related]
29. Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemia.
Body JJ; Dumon JC; Seraj F; Cleeren A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1385-8. PubMed ID: 1592885
[TBL] [Abstract][Full Text] [Related]
30. [The correlation between the serum levels of osteocalcin and 24,25-dihydroxyvitamin D in Paget's disease of bone].
Castro Errecarborde N; de la Piedra Gordo C; Rapado Errazti A
An Med Interna; 1990 Jun; 7(6):286-90. PubMed ID: 2102732
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
van Breukelen FJ; Bijvoet OL; Frijlink WB; Sleeboom HP; Mulder H; van Oosterom AT
Calcif Tissue Int; 1982 Jul; 34(4):321-7. PubMed ID: 6814719
[TBL] [Abstract][Full Text] [Related]
32. Raised serum calcium in tuberculosis patients in Africa.
Davies PD; Church HA; Brown RC; Woodhead JS
Eur J Respir Dis; 1987 Nov; 71(5):341-4. PubMed ID: 3443156
[TBL] [Abstract][Full Text] [Related]
33. Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women.
Finkelstein JS; Schoenfeld DA
J Clin Endocrinol Metab; 1999 Jun; 84(6):2151-6. PubMed ID: 10372724
[TBL] [Abstract][Full Text] [Related]
34. Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans.
Brent GA; LeBoff MS; Seely EW; Conlin PR; Brown EM
J Clin Endocrinol Metab; 1988 Nov; 67(5):944-50. PubMed ID: 3141451
[TBL] [Abstract][Full Text] [Related]
35. Effects of fasting, feeding, and bisphosphonate administration on serum calcitriol levels in phosphate-deprived rats.
Felsenfeld AJ; Jara A; Avedian G; Kleeman CR
Kidney Int; 2000 Sep; 58(3):1016-22. PubMed ID: 10972666
[TBL] [Abstract][Full Text] [Related]
36. Functional evidence for two types of parathyroid adenoma.
D'Amour P; Weisnagel J; Brossard JH; Ste-Marie LG; Rousseau L; Lepage R
Clin Endocrinol (Oxf); 1998 May; 48(5):593-601. PubMed ID: 9666871
[TBL] [Abstract][Full Text] [Related]
37. Effect of direction and rate of change of calcium on parathyroid hormone secretion in uraemia.
Cunningham J; Altmann P; Gleed JH; Butter KC; Marsh FP; O'Riordan JL
Nephrol Dial Transplant; 1989; 4(5):339-44. PubMed ID: 2505183
[TBL] [Abstract][Full Text] [Related]
38. [Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism].
Kotzmann H; Svoboda T; Bernecker P; Clodi M; Woloszczuk W; Niederle B; Waldhäusl W; Luger A
Wien Klin Wochenschr; 1994; 106(13):422-5. PubMed ID: 8091766
[TBL] [Abstract][Full Text] [Related]
39. [Test for hypocalcemia due to calcitonin in the normal subject and in patients with osteoporosis or Paget's disease. Preliminary results].
Renier JC; Bernat M; Brégeon C; Gallois Y; Rebel A; Basle M; Auvinet B; Pitois M
Rev Rhum Mal Osteoartic; 1975 Dec; 42(12):731-7. PubMed ID: 1224158
[TBL] [Abstract][Full Text] [Related]
40. Associations of serum 25-hydroxyvitamin D with circulating PTH, phosphate and calcium in patients with primary hyperparathyroidism.
Jayasena CN; Modi M; Palazzo F; De Silva A; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2013 Jun; 78(6):838-43. PubMed ID: 23036072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
